{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:56:22Z","timestamp":1794369382518,"version":"4.9.0"},"reference-count":300,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.lanepe.2023.100784","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:04:11Z","timestamp":1706745851000},"page":"100784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"special_numbering":"C","title":["Atrial fibrillation: comorbidities, lifestyle, and patient factors"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2429-6980","authenticated-orcid":false,"given":"Eduard","family":"Shantsila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre A.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyoung","family":"Joung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.mayocp.2016.03.002","article-title":"Exercise capacity and atrial fibrillation risk in veterans: a cohort study","volume":"91","author":"Faselis","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MRR.0000000000000232","article-title":"Effects of exercise training on exercise capacity, cardiac function, BMI, and quality of life in patients with atrial fibrillation: a meta-analysis of randomized-controlled trials","volume":"40","author":"Kato","year":"2017","journal-title":"Int J Rehabil Res"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib4","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCULATIONAHA.108.785626","article-title":"Physical activity and incidence of atrial fibrillation in older adults: the cardiovascular health study","volume":"118","author":"Mozaffarian","year":"2008","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.lanepe.2023.100784_bib5","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1177\/2047487318784365","article-title":"Physical activity modifies the risk of atrial fibrillation in obese individuals: the HUNT3 study","volume":"25","author":"Garnvik","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"38","key":"10.1016\/j.lanepe.2023.100784_bib6","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1093\/eurheartj\/ehab597","article-title":"Day-to-day measurement of physical activity and risk of atrial fibrillation","volume":"42","author":"Bonnesen","year":"2021","journal-title":"Eur Heart J"},{"issue":"47","key":"10.1016\/j.lanepe.2023.100784_bib7","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1093\/eurheartj\/eht188","article-title":"Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study","volume":"34","author":"Andersen","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/eurheartj\/ehm555","article-title":"Sinus node disease and arrhythmias in the long-term follow-up of former professional cyclists","volume":"29","author":"Baldesberger","year":"2008","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.115.018220","article-title":"Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial","volume":"133","author":"Malmo","year":"2016","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.39380","article-title":"Effect of high-intensity interval training in patients with atrial fibrillation: a randomized clinical trial","volume":"5","author":"Reed","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib16","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1161\/CIRCULATIONAHA.118.039461","article-title":"Long-term incidence of atrial fibrillation and stroke among cross-country skiers","volume":"140","author":"Svedberg","year":"2019","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.lanepe.2023.100784_bib274","article-title":"The role of social determinants of health in cardiovascular diseases: an umbrella review","volume":"12","author":"Teshale","year":"2023","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib275","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49686-w","article-title":"Physical activity and risk of atrial fibrillation: a nationwide cohort study in general population","volume":"9","author":"Jin","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jacep.2015.04.004","article-title":"Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies","volume":"1","author":"Wong","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib59","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1378\/chest.15-0229","article-title":"Severity of OSA is an independent predictor of incident atrial fibrillation hospitalization in a large sleep-clinic cohort","volume":"148","author":"Cadby","year":"2015","journal-title":"Chest"},{"issue":"13","key":"10.1016\/j.lanepe.2023.100784_bib31","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1177\/2047487318780435","article-title":"Tobacco smoking and the risk of atrial fibrillation: a systematic review and meta-analysis of prospective studies","volume":"25","author":"Aune","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2014.03.048","article-title":"Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis","volume":"64","author":"Larsson","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib49","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3945\/ajcn.110.001305","article-title":"Dietary factors and incident atrial fibrillation: the Framingham Heart Study","volume":"93","author":"Shen","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3945\/ajcn.2010.29627","article-title":"Caffeine consumption and incident atrial fibrillation in women","volume":"92","author":"Conen","year":"2010","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib51","first-page":"448","article-title":"Caffeine intake and atrial fibrillation incidence: dose response meta-analysis of prospective cohort studies","volume":"30","author":"Cheng","year":"2014","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib52","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/2047487320909065","article-title":"Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts","volume":"28","author":"Bazal","year":"2021","journal-title":"Eur J Prev Cardiol"},{"issue":"15","key":"10.1016\/j.lanepe.2023.100784_bib53","article-title":"Coffee consumption and risk of atrial fibrillation in the physicians' health study","volume":"8","author":"Bodar","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib66","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12872-019-1259-0","article-title":"Association and impact of hypertension defined using the 2017 AHA\/ACC guidelines on the risk of atrial fibrillation in the Atherosclerosis Risk in Communities study","volume":"19","author":"Rattani","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib68","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.120.16659","article-title":"Hypertension burden and the risk of new-onset atrial fibrillation: a nationwide population-based study","volume":"77","author":"Lee","year":"2021","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib80","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/CIRCEP.113.001378","article-title":"Paradoxical association of lipoprotein measures with incident atrial fibrillation","volume":"7","author":"Mora","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004044","article-title":"Lipid levels in midlife and risk of atrial fibrillation over 3 decades-Experience from the Swedish AMORIS cohort: a cohort study","volume":"19","author":"Ding","year":"2022","journal-title":"PLoS Med"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib84","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jdiacomp.2018.02.004","article-title":"Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies","volume":"32","author":"Aune","year":"2018","journal-title":"J\u00a0Diabetes Complications"},{"issue":"34","key":"10.1016\/j.lanepe.2023.100784_bib88","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1093\/eurheartj\/ehx316","article-title":"Clinical implication of an impaired fasting glucose and prehypertension related to new onset atrial fibrillation in a healthy Asian population without underlying disease: a nationwide cohort study in Korea","volume":"38","author":"Lee","year":"2017","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib276","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1253\/circj.CJ-11-0780","article-title":"Association between lipid profile and risk of atrial fibrillation","volume":"75","author":"Watanabe","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.lanepe.2023.100784_bib277","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2018.09.056","article-title":"Chronic obstructive pulmonary disease and the development of atrial fibrillation","volume":"276","author":"Grymonprez","year":"2019","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib278","article-title":"Impact of chronic kidney disease on risk of incident atrial fibrillation and subsequent survival in medicare patients","volume":"1","author":"Nelson","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"21","key":"10.1016\/j.lanepe.2023.100784_bib257","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1136\/heartjnl-2015-307808","article-title":"Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013","volume":"101","author":"Martinez","year":"2015","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib258","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12872-021-02133-z","article-title":"Cardio-metabolic outcomes in South Asians compared to White Europeans in the United Kingdom: a matched controlled population-based cohort study","volume":"21","author":"Almulhem","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100784_bib182","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/europace\/euv018","article-title":"Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis--data from the German Competence Network on Atrial Fibrillation","volume":"17","author":"von Eisenhart Rothe","year":"2015","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.hrthm.2022.12.019","article-title":"Increased risk of incident atrial fibrillation in young adults with mental disorders: a nationwide population-based study","volume":"20","author":"Ahn","year":"2023","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib183","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.hrthm.2022.12.019","article-title":"Increased risk of incident atrial fibrillation in young adults with mental disorders: a nationwide population-based study","volume":"20","author":"Ahn","year":"2022","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib279","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","article-title":"Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study","volume":"4","author":"Baber","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1474515116637734","article-title":"Effects of yoga in patients with paroxysmal atrial fibrillation - a randomized controlled study","volume":"16","author":"Wahlstrom","year":"2017","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib280","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/clc.23753","article-title":"Anxiety is associated with higher recurrence of atrial fibrillation after catheter ablation: a meta-analysis","volume":"45","author":"Du","year":"2022","journal-title":"Clin Cardiol"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib177","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.07-0036","article-title":"Depression, anxiety, and quality of life in patients with atrial fibrillation","volume":"132","author":"Thrall","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.lanepe.2023.100784_bib178","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ahj.2017.03.002","article-title":"Does perceived stress increase the risk of atrial fibrillation? A population-based cohort study in Denmark","volume":"188","author":"Graff","year":"2017","journal-title":"Am Heart J"},{"issue":"15","key":"10.1016\/j.lanepe.2023.100784_bib11","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/eurheartj\/ehaa032","article-title":"Physical activity, cardiorespiratory fitness, and cardiovascular outcomes in individuals with atrial fibrillation: the HUNT study","volume":"41","author":"Garnvik","year":"2020","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib12","first-page":"535","article-title":"Self-reported physical activity and major adverse events in patients with atrial fibrillation: a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry","volume":"19","author":"Proietti","year":"2017","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003659","article-title":"Association between exercise habits and stroke, heart failure, and mortality in Korean patients with incident atrial fibrillation: a nationwide population-based cohort study","volume":"18","author":"Ahn","year":"2021","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.mayocp.2021.10.003","article-title":"Association of physical activity with primary cardiac arrest risk in the general population: a nationwide cohort study of the dose-response relationship","volume":"97","author":"Jin","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.38526","article-title":"Association of physical activity level with risk of dementia in a nationwide cohort in Korea","volume":"4","author":"Yoon","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanepe.2023.100784_bib17","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjcard.2022.07.010","article-title":"Usefulness of self-reported physical activity and clinical outcomes in older patients with atrial fibrillation","volume":"181","author":"Dai","year":"2022","journal-title":"Am J Cardiol"},{"issue":"25","key":"10.1016\/j.lanepe.2023.100784_bib18","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1016\/j.jacc.2017.10.063","article-title":"Structure and function of the left atrium and left atrial appendage: AF and stroke implications","volume":"70","author":"Delgado","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/europace\/euac225","article-title":"Short- and long-term risk of atrial fibrillation recurrence after first time ablation according to body mass index: a nationwide Danish cohort study","volume":"25","author":"Tonnesen","year":"2023","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100784_bib25","doi-asserted-by":"crossref","first-page":"640.e9","DOI":"10.1016\/j.amjmed.2012.11.024","article-title":"Body mass index and adverse events in patients with incident atrial fibrillation","volume":"126","author":"Overvad","year":"2013","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib61","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ahj.2014.12.024","article-title":"Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)","volume":"169","author":"Holmqvist","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.lanepe.2023.100784_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijcard.2016.07.220","article-title":"Relationship between smoking and adverse outcomes in patients with atrial fibrillation: a meta-analysis and systematic review","volume":"222","author":"Zhu","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.lanepe.2023.100784_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2261-5-20","article-title":"Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK","volume":"5","author":"Ruigomez","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib39","article-title":"Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation","volume":"4","author":"Qiao","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib40","article-title":"Impact of alcohol consumption on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation","volume":"5","author":"Takigawa","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"15","key":"10.1016\/j.lanepe.2023.100784_bib41","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1136\/heartjnl-2013-304036","article-title":"Alcohol intake and prognosis of atrial fibrillation","volume":"99","author":"Overvad","year":"2013","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib45","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/europace\/euaa340","article-title":"Effect of alcohol consumption on the risk of adverse events in atrial fibrillation: from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) registry","volume":"23","author":"Lim","year":"2021","journal-title":"Europace"},{"issue":"46","key":"10.1016\/j.lanepe.2023.100784_bib42","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1093\/eurheartj\/ehab315","article-title":"Lower risk of stroke after alcohol abstinence in patients with incident atrial fibrillation: a nationwide population-based cohort study","volume":"42","author":"Lee","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanepe.2023.100784_bib73","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ahj.2016.05.001","article-title":"Blood pressure control and stroke or bleeding risk in anticoagulated patients with atrial fibrillation: results from the ROCKET AF Trial","volume":"178","author":"Vemulapalli","year":"2016","journal-title":"Am Heart J"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib281","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/2047487318777387","article-title":"Job strain and atrial fibrillation - results from the Swedish Longitudinal Occupational Survey of Health and meta-analysis of three studies","volume":"25","author":"Fransson","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib282","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jacc.2018.05.076","article-title":"Ideal blood pressure in patients with atrial fibrillation","volume":"72","author":"Kim","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib76","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/eurheartj\/ehy877","article-title":"Effect of hypertension duration and blood pressure level on ischaemic stroke risk in atrial fibrillation: nationwide data covering the entire Korean population","volume":"40","author":"Kim","year":"2019","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib75","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/HYPERTENSIONAHA.119.14388","article-title":"Blood pressure control and dementia risk in midlife patients with atrial fibrillation","volume":"75","author":"Kim","year":"2020","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib94","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/europace\/euv214","article-title":"Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"17","author":"Anselmino","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.lanepe.2023.100784_bib145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2015.02.041","article-title":"Primary prophylactic anticoagulation is mandatory if noncompaction is associated with atrial fibrillation or heart failure","volume":"184","author":"Finsterer","year":"2015","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib106","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/ehf2.13264","article-title":"Stroke and systemic embolism in patients with atrial fibrillation and heart failure according to heart failure type","volume":"8","author":"Uhm","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.lanepe.2023.100784_bib146","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2016.08.011","article-title":"Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: a report from the EURObservational research programme pilot survey on atrial fibrillation (EORP-AF) general registry","volume":"181","author":"Proietti","year":"2016","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100784_bib283","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006322","article-title":"Acute exacerbation of chronic obstructive pulmonary disease and subsequent risk of emergency department visits and hospitalizations for atrial fibrillation","volume":"11","author":"Hirayama","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib284","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266046","article-title":"Chronic kidney disease and atrial fibrillation: a dangerous combination","volume":"17","author":"Ocak","year":"2022","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.lanepe.2023.100784_bib196","article-title":"Atrial fibrillation and the risk of early-onset dementia: a systematic review and meta-analysis","volume":"11","author":"Giannone","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.lanepe.2023.100784_bib223","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2019.01.005","article-title":"Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation","volume":"211","author":"Madhavan","year":"2019","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib217","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cger.2017.02.002","article-title":"Frailty in older persons","volume":"33","author":"Cesari","year":"2017","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jgs.16178","article-title":"Geriatric elements and oral anticoagulant prescribing in older atrial fibrillation patients: sage-af","volume":"68","author":"Saczynski","year":"2020","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib228","first-page":"46","article-title":"Assessing the appropriateness of oral anticoagulation for atrial fibrillation in advanced frailty: use of stroke and bleeding risk-prediction models","volume":"6","author":"O'Caoimh","year":"2017","journal-title":"J\u00a0Frailty Aging"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib220","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afac192","article-title":"Epidemiology and impact of frailty in patients with atrial fibrillation in Europe","volume":"51","author":"Proietti","year":"2022","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib285","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1016\/j.ijcard.2013.07.179","article-title":"Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation","volume":"168","author":"Guo","year":"2013","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib222","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.ijnurstu.2015.04.005","article-title":"Frail phenotype and mortality prediction: a systematic review and meta-analysis of prospective cohort studies","volume":"52","author":"Chang","year":"2015","journal-title":"Int J Nurs Stud"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib187","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ehjqcco\/qcab077","article-title":"The effect of mental health conditions on the use of oral anticoagulation therapy in patients with atrial fibrillation: the FinACAF study","volume":"8","author":"Jaakkola","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"35","key":"10.1016\/j.lanepe.2023.100784_bib190","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029997","article-title":"Impact of social determinants of health on anticoagulant use among patients with atrial fibrillation: systemic review and meta-analysis","volume":"101","author":"Khatib","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib286","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afn293","article-title":"The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation","volume":"38","author":"Perera","year":"2009","journal-title":"Age Ageing"},{"issue":"19","key":"10.1016\/j.lanepe.2023.100784_bib30","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.lanepe.2023.100784_bib26","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.lanepe.2023.100784_bib27","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (Legacy)","volume":"65","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib28","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/europace\/euab122","article-title":"Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial","volume":"23","author":"Gessler","year":"2021","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib287","article-title":"Obesity, physical activity, and their interaction in incident atrial fibrillation in postmenopausal women","volume":"3","author":"Azarbal","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib62","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.amjcard.2015.08.046","article-title":"Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea","volume":"116","author":"Qureshi","year":"2015","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib288","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/CIRCEP.109.858381","article-title":"Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure","volume":"3","author":"Patel","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib34","first-page":"2238","article-title":"Smoking cessation after diagnosis of new-onset atrial fibrillation and the risk of stroke and death","volume":"10","author":"Lee","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.17132","article-title":"Risk of dementia after smoking cessation in patients with newly diagnosed atrial fibrillation","volume":"5","author":"Lee","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185228","article-title":"Past alcohol consumption and incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"12","author":"Dixit","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100784_bib289","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.hrthm.2022.06.016","article-title":"Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: a randomized controlled trial","volume":"19","author":"Hunt","year":"2022","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1817591","article-title":"Alcohol abstinence in drinkers with atrial fibrillation","volume":"382","author":"Voskoboinik","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib290","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.121.009770","article-title":"Alcohol consumption reduction and clinical outcomes of catheter ablation for atrial fibrillation","volume":"14","author":"Takahashi","year":"2021","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib85","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s11606-010-1340-y","article-title":"Diabetes mellitus, glycemic control, and risk of atrial fibrillation","volume":"25","author":"Dublin","year":"2010","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.lanepe.2023.100784_bib86","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2018.03.099","article-title":"Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases","volume":"262","author":"Larsson","year":"2018","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib87","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/heartjnl-2011-300503","article-title":"Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study","volume":"98","author":"Huxley","year":"2012","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib291","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/europace\/euv021","article-title":"Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials","volume":"17","author":"Emdin","year":"2015","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib92","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12872-017-0531-4","article-title":"Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib292","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijcard.2011.08.081","article-title":"Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes","volume":"156","author":"Chao","year":"2012","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100784_bib293","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jce.14029","article-title":"Impact of coronary artery disease and revascularization on recurrence of atrial fibrillation after catheter ablation: importance of ischemia in managing atrial fibrillation","volume":"30","author":"Hiraya","year":"2019","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib123","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanepe.2023.100784_bib294","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijcard.2014.12.039","article-title":"Presence and extent of coronary artery disease as predictor for AF recurrences after catheter ablation: the Leipzig Heart Center AF Ablation Registry","volume":"181","author":"Kornej","year":"2015","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib119","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib125","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1038\/s41598-021-84256-z","article-title":"Reduction of mortality by catheter ablation in real-world atrial fibrillation patients with heart failure","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"issue":"14","key":"10.1016\/j.lanepe.2023.100784_bib295","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100784_bib296","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007414","article-title":"Catheter ablation versus medical therapy for atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Asad","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib297","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.21037\/jtd-22-550","article-title":"The effectiveness of SGLT2 inhibitor in the incidence of atrial fibrillation\/atrial flutter in patients with type 2 diabetes mellitus\/heart failure: a systematic review and meta-analysis","volume":"14","author":"Wang","year":"2022","journal-title":"J\u00a0Thorac Dis"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib298","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/eurheartj\/ehaa943","article-title":"Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes","volume":"42","author":"Abraham","year":"2021","journal-title":"Eur Heart J"},{"issue":"35","key":"10.1016\/j.lanepe.2023.100784_bib149","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.1093\/eurheartj\/ehab453","article-title":"Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients","volume":"42","author":"Romiti","year":"2021","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.lanepe.2023.100784_bib172","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/jama.2019.0692","article-title":"Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Mark","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.lanepe.2023.100784_bib300","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.840452","article-title":"Associations of antidepressants with atrial fibrillation and ventricular arrhythmias: a systematic review and meta-analysis","volume":"9","author":"Cao","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2459\/JCM.0000000000001386","article-title":"Effects of different exercise types on quality of life for patients with atrial fibrillation: a systematic review and meta-analysis","volume":"24","author":"AbuElkhair","year":"2023","journal-title":"J\u00a0Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib20","article-title":"Exercise-based cardiac rehabilitation for adults with atrial fibrillation","volume":"2","author":"Buckley","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5 Pt B","key":"10.1016\/j.lanepe.2023.100784_bib21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.hrthm.2020.02.013","article-title":"Physical activity and atrial fibrillation: data from wearable fitness trackers","volume":"17","author":"Semaan","year":"2020","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.40071","article-title":"The effects of implementing a mobile health-technology supported pathway on atrial fibrillation-related adverse events among patients with multimorbidity: the mAFA-II randomized clinical trial","volume":"4","author":"Yao","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib29","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1093\/europace\/euy117","article-title":"PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study","volume":"20","author":"Middeldorp","year":"2018","journal-title":"Europace"},{"issue":"13","key":"10.1016\/j.lanepe.2023.100784_bib32","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jacc.2019.07.060","article-title":"Childhood tobacco smoke exposure and risk of atrial fibrillation in adulthood","volume":"74","author":"Groh","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.lanepe.2023.100784_bib36","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.jacc.2016.08.074","article-title":"Alcohol and atrial fibrillation: a sobering review","volume":"68","author":"Voskoboinik","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib46","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1097\/MJT.0b013e3181df8cf8","article-title":"Caffeine-related atrial fibrillation","volume":"17","author":"Artin","year":"2010","journal-title":"Am J Ther"},{"issue":"6647","key":"10.1016\/j.lanepe.2023.100784_bib47","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/38160","article-title":"Caffeine alters plasma adenosine levels","volume":"389","author":"Conlay","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.lanepe.2023.100784_bib48","first-page":"22","article-title":"Beneficial effects of oral pure caffeine on oxidative stress","volume":"10","author":"Metro","year":"2017","journal-title":"J\u00a0Clin Transl Endocrinol"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib54","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/2047487318772945","article-title":"Caffeine intake reduces incident atrial fibrillation at a population level","volume":"25","author":"Casiglia","year":"2018","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib55","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.CIR.0000136587.68725.8E","article-title":"Association of atrial fibrillation and obstructive sleep apnea","volume":"110","author":"Gami","year":"2004","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.lanepe.2023.100784_bib56","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/eurheartj\/ehn214","article-title":"Prevalence of sleep disordered breathing in paroxysmal and persistent atrial fibrillation patients with normal left ventricular function","volume":"29","author":"Stevenson","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanepe.2023.100784_bib57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijcard.2016.12.120","article-title":"Obstructive sleep and atrial fibrillation: pathophysiological mechanisms and therapeutic implications","volume":"230","author":"Goudis","year":"2017","journal-title":"Int J Cardiol"},{"issue":"23","key":"10.1016\/j.lanepe.2023.100784_bib58","article-title":"Causal effect of obstructive sleep apnea on atrial fibrillation: a mendelian randomization study","volume":"10","author":"Chen","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100784_bib60","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jacep.2022.04.015","article-title":"Impact of CPAP on the atrial fibrillation substrate in obstructive sleep apnea: the SLEEP-AF study","volume":"8","author":"Nalliah","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib63","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1378\/chest.15-0903","article-title":"STOP-bang questionnaire: a practical approach to screen for obstructive sleep apnea","volume":"149","author":"Chung","year":"2016","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib64","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1160\/TH16-11-0825","article-title":"Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population-based cohorts of 20 million participants","volume":"117","author":"Allan","year":"2017","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib65","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/01.ede.0000091649.26364.c0","article-title":"Rising rates of hospital admissions for atrial fibrillation","volume":"14","author":"Friberg","year":"2003","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12933-023-01736-4","article-title":"Accumulated hypertension burden on atrial fibrillation risk in diabetes mellitus: a nationwide population study","volume":"22","author":"Choi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib69","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.119.13708","article-title":"Blood pressure variability and incidence of new-onset atrial fibrillation: a nationwide population-based study","volume":"75","author":"Lee","year":"2020","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib70","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/HYPERTENSIONAHA.117.08934","article-title":"Atrial fibrillation and hypertension","volume":"70","author":"Dzeshka","year":"2017","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib71","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib72","article-title":"Blood pressure control and risk of stroke or systemic embolism in patients with atrial fibrillation: results from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial","volume":"4","author":"Rao","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib74","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.amjcard.2015.07.032","article-title":"Comparison of characteristics and outcomes of dabigatran versus warfarin in hypertensive patients with atrial fibrillation (from the RE-LY trial)","volume":"116","author":"Nagarakanti","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lanepe.2023.100784_bib78","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-61-5-888","article-title":"Risk factors in coronary heart disease. AN evaluation of several serum lipids as predictors of coronary heart disease; the framingham study","volume":"61","author":"Kannel","year":"1964","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib79","article-title":"Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium","volume":"2","author":"Alonso","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib81","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/cvr\/cvab017","article-title":"Relationship between lipoproteins, thrombosis, and atrial fibrillation","volume":"118","author":"Ding","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib83","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib89","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial fibrillation and diabetes mellitus: JACC review topic of the week","volume":"74","author":"Wang","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.lanepe.2023.100784_bib90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejim.2022.04.026","article-title":"Impact of diabetes on the management and outcomes in atrial fibrillation: an analysis from the ESC-EHRA EORP-AF Long-Term General Registry","volume":"103","author":"Ding","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.lanepe.2023.100784_bib91","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12933-014-0123-x","article-title":"Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in\u00a0vitro studies","volume":"13","author":"Chang","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101582","article-title":"The effect of sodium-glucose Co-transporter 2 inhibitors on stroke and atrial fibrillation: a systematic review and meta-analysis","volume":"48","author":"Fatima","year":"2023","journal-title":"Curr Probl Cardiol"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib95","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41569-018-0080-2","article-title":"Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs","volume":"16","author":"Patti","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"21","key":"10.1016\/j.lanepe.2023.100784_bib96","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1161\/CIRCULATIONAHA.114.014145","article-title":"Atrial fibrillation and risk of ST-segment-elevation versus non-ST-segment-elevation myocardial infarction: the atherosclerosis risk in Communities (ARIC) study","volume":"131","author":"Soliman","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib97","article-title":"Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study","volume":"7","author":"Lee","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib98","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002321","article-title":"Early coronary angiography and survival after out-of-hospital cardiac arrest","volume":"8","author":"Vyas","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib99","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/europace\/euy174","volume":"21","author":"Lip","year":"2018","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib101","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bbrc.2003.10.025","article-title":"Suppressor mechanism of serum thymic factor on tumor necrosis factor-alpha-induced apoptosis in the mouse pancreatic beta-cell line","volume":"311","author":"Yasuda","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib102","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.30","article-title":"Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey","volume":"16","author":"van Deursen","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"6a","key":"10.1016\/j.lanepe.2023.100784_bib103","doi-asserted-by":"crossref","first-page":"2d","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am J Cardiol"},{"issue":"25","key":"10.1016\/j.lanepe.2023.100784_bib104","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100784_bib105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A\u00a0meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur J Heart Fail"},{"issue":"9921","key":"10.1016\/j.lanepe.2023.100784_bib107","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib108","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/ejhf.343","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials","volume":"17","author":"Xiong","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"27","key":"10.1016\/j.lanepe.2023.100784_bib109","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib110","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.amjcard.2019.12.025","article-title":"Strict versus lenient versus poor rate control among patients with atrial fibrillation and heart failure (from the get with the guidelines - heart failure program)","volume":"125","author":"Hess","year":"2020","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib111","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejhf.1389","article-title":"Association of heart rate with mortality in sinus rhythm and atrial fibrillation in heart failure with preserved ejection fraction","volume":"21","author":"Sartipy","year":"2019","journal-title":"Eur J Heart Fail"},{"issue":"9961","key":"10.1016\/j.lanepe.2023.100784_bib112","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.lanepe.2023.100784_bib113","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanepe.2023.100784_bib114","doi-asserted-by":"crossref","first-page":"n991","DOI":"10.1136\/bmj.n991","article-title":"Treatment timing and the effects of rhythm control strategy in patients with atrial fibrillation: nationwide cohort study","volume":"373","author":"Kim","year":"2021","journal-title":"BMJ"},{"issue":"13","key":"10.1016\/j.lanepe.2023.100784_bib115","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.0693","article-title":"Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial","volume":"321","author":"Packer","year":"2019","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.lanepe.2023.100784_bib116","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/eurheartj\/ehz085","article-title":"Atrial fibrillation ablation in practice: assessing CABANA generalizability","volume":"40","author":"Noseworthy","year":"2019","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100784_bib117","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa0803778","article-title":"Effect of dronedarone on cardiovascular events in atrial fibrillation","volume":"360","author":"Hohnloser","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib118","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2021","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib120","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/CIRCULATIONAHA.122.060274","article-title":"Early rhythm control in patients with atrial fibrillation and high comorbidity burden","volume":"146","author":"Rillig","year":"2022","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib121","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.7326\/M21-4798","article-title":"Early rhythm control therapy for atrial fibrillation in low-risk patients : a nationwide propensity score-weighted study","volume":"175","author":"Kim","year":"2022","journal-title":"Ann Intern Med"},{"issue":"17","key":"10.1016\/j.lanepe.2023.100784_bib122","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial","volume":"133","author":"Di Biase","year":"2016","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100784_bib124","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.hrthm.2020.02.030","article-title":"Generalizability of the CASTLE-AF trial: catheter ablation for patients with atrial fibrillation and heart failure in routine practice","volume":"17","author":"Noseworthy","year":"2020","journal-title":"Heart Rhythm"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib126","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007731","article-title":"Catheter ablation versus best medical therapy in patients with persistent atrial fibrillation and congestive heart failure: the randomized AMICA trial","volume":"12","author":"Kuck","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"17","key":"10.1016\/j.lanepe.2023.100784_bib127","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa0708234","article-title":"Pulmonary-vein isolation for atrial fibrillation in patients with heart failure","volume":"359","author":"Khan","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100784_bib128","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/hrt.2010.207340","article-title":"Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial","volume":"97","author":"MacDonald","year":"2011","journal-title":"Heart"},{"issue":"18","key":"10.1016\/j.lanepe.2023.100784_bib129","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A\u00a0randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A\u00a0randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib131","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacep.2015.02.018","article-title":"Catheter ablation for atrial fibrillation in heart failure patients: a meta-analysis of randomized controlled trials","volume":"1","author":"Al Halabi","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"issue":"16","key":"10.1016\/j.lanepe.2023.100784_bib132","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.jacc.2017.08.041","article-title":"Catheter ablation versus medical rate control in atrial fibrillation and systolic dysfunction: the CAMERA-MRI study","volume":"70","author":"Prabhu","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib133","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.amjcard.2018.05.009","article-title":"Meta-analysis comparing catheter-guided ablation versus conventional medical therapy for patients with atrial fibrillation and heart failure with reduced ejection fraction","volume":"122","author":"Elgendy","year":"2018","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib134","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jacep.2018.03.003","article-title":"The clinical benefits and mortality reduction associated with catheter ablation in subjects with atrial fibrillation: a systematic review and meta-analysis","volume":"4","author":"Khan","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"issue":"15","key":"10.1016\/j.lanepe.2023.100784_bib135","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMoa2306037","article-title":"Catheter ablation in end-stage heart failure with atrial fibrillation","volume":"389","author":"Sohns","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib136","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1253\/circj.CJ-14-1193","article-title":"Atrial arrhythmias in arrhythmogenic cardiomyopathy: at the beginning or at the end of the disease story?","volume":"79","author":"Peters","year":"2015","journal-title":"Circ J"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib137","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/europace\/eur245","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"13","author":"Ackerman","year":"2011","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib138","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/europace\/euy064","article-title":"Atrial fibrillation in patients with inherited cardiomyopathies","volume":"21","author":"Yeung","year":"2019","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib139","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0735-1097(01)01727-2","article-title":"Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy","volume":"39","author":"Maron","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.lanepe.2023.100784_bib140","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.lanepe.2023.100784_bib141","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/heartjnl-2016-310720","article-title":"Impact of atrial fibrillation on the clinical course of apical hypertrophic cardiomyopathy","volume":"103","author":"Lee","year":"2017","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib142","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/STROKEAHA.121.034213","article-title":"Ischemic stroke in patients with hypertrophic cardiomyopathy according to presence or absence of atrial fibrillation","volume":"53","author":"Fauchier","year":"2022","journal-title":"Stroke"},{"issue":"23","key":"10.1016\/j.lanepe.2023.100784_bib143","article-title":"Atrial fibrillation in patients with cardiomyopathy: prevalence and clinical outcomes from real-world data","volume":"10","author":"Buckley","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"39","key":"10.1016\/j.lanepe.2023.100784_bib144","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC)","volume":"35","author":"Authors\/Task Force m","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lanepe.2023.100784_bib147","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/COPD.S174443","article-title":"A\u00a0prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population","volume":"14","author":"Rodriguez-Manero","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib148","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/eurheartj\/ehaa822","article-title":"Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective","volume":"42","author":"Simons","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib150","first-page":"614","article-title":"Incident atrial fibrillation in relation to ventilatory parameters: a prospective cohort study","volume":"39","author":"Noubiap","year":"2023","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib151","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/europace\/eur406","article-title":"Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey","volume":"14","author":"Pisters","year":"2012","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib152","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/CIRCEP.110.960435","article-title":"Catheter ablation of atrial fibrillation in patients with chronic lung disease","volume":"4","author":"Roh","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib153","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1540-8167.2012.02448.x","article-title":"Impact of chronic obstructive pulmonary disease on procedural outcomes and quality of life in patients with atrial fibrillation undergoing catheter ablation","volume":"24","author":"Gu","year":"2013","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib154","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-2600(15)00518-4","article-title":"Cardiac effects of current treatments of chronic obstructive pulmonary disease","volume":"4","author":"Lahousse","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib155","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1513\/AnnalsATS.201708-626OC","article-title":"Beta-blocker therapy and clinical outcomes in patients with moderate chronic obstructive pulmonary disease and heightened cardiovascular risk. An observational substudy of SUMMIT","volume":"15","author":"Dransfield","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib156","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.hrthm.2018.06.044","article-title":"Rate control and clinical outcomes in patients with atrial fibrillation and obstructive lung disease","volume":"15","author":"You","year":"2018","journal-title":"Heart Rhythm"},{"issue":"10082","key":"10.1016\/j.lanepe.2023.100784_bib157","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(17)30505-6","article-title":"Estimates and 25-year trends of the global burden of disease attributable to ambient air pollution: an analysis of data from the Global Burden of Diseases Study 2015","volume":"389","author":"Cohen","year":"2017","journal-title":"Lancet"},{"issue":"3-4","key":"10.1016\/j.lanepe.2023.100784_bib158","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijheh.2007.06.005","article-title":"Vulnerability to air pollution health effects","volume":"211","author":"Makri","year":"2008","journal-title":"Int J Hyg Environ Health"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib159","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/joim.13467","article-title":"Ambient air pollution and cardiovascular diseases: an umbrella review of systematic reviews and meta-analyses","volume":"291","author":"de Bont","year":"2022","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/jebm.12380","article-title":"A\u00a0time-to-event analysis on air pollutants with the risk of cardiovascular disease and mortality: a systematic review and meta-analysis of 84 cohort studies","volume":"13","author":"Pranata","year":"2020","journal-title":"J\u00a0Evid Based Med"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib161","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.hrtlng.2016.08.001","article-title":"Association between air pollution and development of atrial fibrillation: a meta-analysis of observational studies","volume":"45","author":"Shao","year":"2016","journal-title":"Heart Lung"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib162","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10840-020-00864-1","article-title":"Association between fine particulate matter and atrial fibrillation in implantable cardioverter defibrillator patients: a systematic review and meta-analysis","volume":"59","author":"Yue","year":"2020","journal-title":"J\u00a0Interv Card Electrophysiol"},{"key":"10.1016\/j.lanepe.2023.100784_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.111508","article-title":"Association between air pollutants and atrial fibrillation in general population: a systematic review and meta-analysis","volume":"208","author":"Yue","year":"2021","journal-title":"Ecotoxicol Environ Saf"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib164","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrneph.2018.19","article-title":"Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction","volume":"14","author":"Potpara","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib165","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/europace\/euv202","volume":"17","author":"Boriani","year":"2015","journal-title":"Europace"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib166","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1161\/STROKEAHA.118.021387","article-title":"Impact of renal function on outcomes with edoxaban in real-world patients with atrial fibrillation","volume":"49","author":"Yu","year":"2018","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib167","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.116.022361","article-title":"Impact of renal function on outcomes with edoxaban in the ENGAGE AF-TIMI 48 trial","volume":"134","author":"Bohula","year":"2016","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib168","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/jamacardio.2016.1170","article-title":"Efficacy and safety of apixaban compared with warfarin in patients with atrial fibrillation in relation to renal function over time: insights from the ARISTOTLE randomized clinical trial","volume":"1","author":"Hijazi","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"19","key":"10.1016\/j.lanepe.2023.100784_bib169","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/eurheartj\/ehr342","article-title":"Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment","volume":"32","author":"Fox","year":"2011","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.lanepe.2023.100784_bib170","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.118.035418","article-title":"Outcomes associated with apixaban use in end-stage kidney disease patients with atrial fibrillation in the United States","volume":"138","author":"Siontis","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100784_bib171","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.amjmed.2019.04.013","article-title":"Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and severe kidney disease or undergoing hemodialysis","volume":"132","author":"Coleman","year":"2019","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib173","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.hrthm.2010.10.047","article-title":"Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: a mid-term follow-up","volume":"8","author":"Naruse","year":"2011","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib174","article-title":"Negative affect and risk of atrial fibrillation: mesa","volume":"8","author":"Garg","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib176","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12933-022-01682-7","article-title":"Impact of mental disorders on the risk of atrial fibrillation in patients with diabetes mellitus: a nationwide population-based study","volume":"21","author":"Bae","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.lanepe.2023.100784_bib179","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2022.05.048","article-title":"Psychological factors and risk of atrial fibrillation: a meta-analysis and systematic review","volume":"362","author":"Wu","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.lanepe.2023.100784_bib181","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijcard.2019.11.107","article-title":"Symptoms of anxiety and depression and risk of atrial fibrillation-The HUNT study","volume":"306","author":"Feng","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.lanepe.2023.100784_bib184","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijcard.2016.11.185","article-title":"Antipsychotic treatment is associated with risk of atrial fibrillation: a nationwide nested case-control study","volume":"227","author":"Chou","year":"2017","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib185","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1111\/bcp.15337","article-title":"Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: a nationwide cohort study","volume":"88","author":"Hojen","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib186","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.10096","article-title":"Association between bipolar disorder or schizophrenia and oral anticoagulation use in Danish adults with incident or prevalent atrial fibrillation","volume":"4","author":"Fenger-Gron","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.lanepe.2023.100784_bib188","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jpsychires.2022.11.002","article-title":"Anticoagulation therapy and outcomes in patients with atrial fibrillation and serious mental illness: a systematic review and meta-analysis","volume":"156","author":"Farran","year":"2022","journal-title":"J\u00a0Psychiatr Res"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib189","article-title":"Mental health conditions and nonpersistence of direct oral anticoagulant use in patients with incident atrial fibrillation: a nationwide cohort study","volume":"11","author":"Teppo","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib191","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018209","article-title":"Atrial fibrillation in patients with severe mental disorders and the risk of stroke, fatal thromboembolic events and bleeding: a nationwide cohort study","volume":"7","author":"Sogaard","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib192","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FJC.0b013e3182609a74","article-title":"Influences of donepezil on cardiovascular system--possible therapeutic benefits for heart failure--donepezil cardiac test registry (DOCTER) study","volume":"60","author":"Kubo","year":"2012","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib193","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1007\/s11606-021-06954-8","article-title":"Atrial fibrillation is associated with cognitive impairment, all-cause dementia, vascular dementia, and Alzheimer's disease: a systematic review and meta-analysis","volume":"36","author":"Papanastasiou","year":"2021","journal-title":"J\u00a0Gen Intern Med"},{"issue":"28","key":"10.1016\/j.lanepe.2023.100784_bib194","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz386","article-title":"Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a population-based cohort","volume":"40","author":"Kim","year":"2019","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib195","first-page":"3665","article-title":"Atrial fibrillation increases the risk of early-onset dementia in the general population: data from a population-based cohort","volume":"9","author":"Kim","year":"2020","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib197","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2022-000370","article-title":"Impact of cognitive impairment on clinical outcomes in elderly patients with atrial fibrillation: ANAFIE Registry","volume":"5","author":"Nagata","year":"2023","journal-title":"BMJ Neurol Open"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib198","article-title":"Association of atrial fibrillation with cognitive decline and dementia over 20 Years: the ARIC-NCS (atherosclerosis risk in Communities neurocognitive study)","volume":"7","author":"Chen","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib199","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hrthm.2009.12.004","article-title":"Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia","volume":"7","author":"Bunch","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.lanepe.2023.100784_bib200","article-title":"Atrial fibrillation and the risk of early-onset dementia an cognitive decline: an updated review","author":"Kogelschatz","year":"2023","journal-title":"Trends Cardiovasc Med"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib201","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/europace\/eux220","article-title":"Atrial fibrillation is associated with decreased total cerebral blood flow and brain perfusion","volume":"20","author":"Gardarsdottir","year":"2018","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib202","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0002-9149(98)00693-6","article-title":"Influence of heart rate on stroke volume variability in atrial fibrillation in patients with normal and impaired left ventricular function","volume":"82","author":"Kerr","year":"1998","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100784_bib203","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jacc.2018.12.039","article-title":"Relationships of overt and silent brain lesions with cognitive function in patients with atrial fibrillation","volume":"73","author":"Conen","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"47","key":"10.1016\/j.lanepe.2023.100784_bib204","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1093\/eurheartj\/ehaa726","article-title":"Less dementia after catheter ablation for atrial fibrillation: a nationwide cohort study","volume":"41","author":"Kim","year":"2020","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10840-022-01196-y","article-title":"Impact of catheter ablation versus medical therapy on cognitive function in atrial fibrillation: a systematic review","volume":"65","author":"Bodagh","year":"2022","journal-title":"J\u00a0Interv Card Electrophysiol"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib206","first-page":"140","article-title":"Association of catheter ablation and reduced incidence of dementia among patients with atrial fibrillation during long-term follow-up: a systematic review and meta-analysis of observational studies","volume":"9","author":"Saglietto","year":"2022","journal-title":"J\u00a0Cardiovasc Dev Dis"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib207","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/ene.15701","article-title":"Cognitive phenotypes and factors associated with cognitive decline in a cohort of older patients with atrial fibrillation: the Strat-AF study","volume":"30","author":"Salvadori","year":"2023","journal-title":"Eur J Neurol"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib208","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/eurheartj\/ehx579","article-title":"Less dementia with oral anticoagulation in atrial fibrillation","volume":"39","author":"Friberg","year":"2018","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.lanepe.2023.100784_bib209","doi-asserted-by":"crossref","first-page":"e1732","DOI":"10.1212\/WNL.0000000000006456","article-title":"Atrial fibrillation, antithrombotic treatment, and cognitive aging: a population-based study","volume":"91","author":"Ding","year":"2018","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib210","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14269","article-title":"A\u00a0systematic review and meta-analysis to determine the effect of oral anticoagulants on incidence of dementia in patients with atrial fibrillation","volume":"75","author":"Lin","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib211","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1161\/STROKEAHA.120.033338","article-title":"Comparing warfarin and 4 direct oral anticoagulants for the risk of dementia in patients with atrial fibrillation","volume":"52","author":"Lee","year":"2021","journal-title":"Stroke"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib212","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euaa192","article-title":"Association of anticoagulant therapy with risk of dementia among patients with atrial fibrillation","volume":"23","author":"Kim","year":"2021","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib213","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afab248","article-title":"Association of rhythm control with incident dementia among patients with atrial fibrillation: a nationwide population-based cohort study","volume":"51","author":"Kim","year":"2022","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib214","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2337\/dc22-1705","article-title":"Association of sodium-glucose cotransporter 2 inhibitors with time to dementia: a population-based cohort study","volume":"46","author":"Wu","year":"2023","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100784_bib215","article-title":"Low risk of dementia in patients with newly diagnosed atrial fibrillation and a clustering of healthy lifestyle behaviors: a nationwide population-based cohort study","volume":"11","author":"Park","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib216","first-page":"1696","article-title":"The effect of integrated care management on dementia in atrial fibrillation","volume":"9","author":"Yang","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.lanepe.2023.100784_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101527","article-title":"Impact of frailty on all-cause mortality and major bleeding in patients with atrial fibrillation: a meta-analysis","volume":"73","author":"He","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib219","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","article-title":"Prevalence of frailty in community-dwelling older persons: a systematic review","volume":"60","author":"Collard","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib221","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ageing\/afy180","article-title":"Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis","volume":"48","author":"Wilkinson","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.lanepe.2023.100784_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101652","article-title":"Frailty prevalence and impact on outcomes in patients with atrial fibrillation: a systematic review and meta-analysis of 1,187,000 patients","volume":"79","author":"Proietti","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib226","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ageing\/afaa265","article-title":"Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study","volume":"50","author":"Wilkinson","year":"2021","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib227","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/qjmed\/hct060","article-title":"Factors that influence awareness and treatment of atrial fibrillation in older adults","volume":"106","author":"Frewen","year":"2013","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib229","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12916-020-01870-w","article-title":"Clinical outcomes in patients with atrial fibrillation and frailty: insights from the ENGAGE AF-TIMI 48 trial","volume":"18","author":"Wilkinson","year":"2020","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/joim.13140","article-title":"Oral anticoagulants for nonvalvular atrial fibrillation in frail elderly patients: insights from the ARISTOPHANES study","volume":"289","author":"Lip","year":"2021","journal-title":"J\u00a0Intern Med"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib231","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/STROKEAHA.121.036757","article-title":"Effectiveness and safety of anticoagulation therapy in frail patients with atrial fibrillation","volume":"53","author":"Kim","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.lanepe.2023.100784_bib232","article-title":"Impact of frailty on early rhythm control outcomes in older adults with atrial fibrillation: a nationwide cohort study","volume":"9","author":"Yu","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib233","first-page":"668","article-title":"Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: a nationwide cohort study","volume":"36","author":"Yang","year":"2020","journal-title":"J\u00a0Arrhythm"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib234","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.mayocp.2019.06.012","article-title":"Long-term relationship between atrial fibrillation, multimorbidity and oral anticoagulant drug use","volume":"94","author":"Proietti","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib235","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1055\/a-1467-2993","article-title":"Improving stroke risk prediction in the general population: a comparative assessment of common clinical rules, a new multimorbid index, and machine-learning-based algorithms","volume":"122","author":"Lip","year":"2022","journal-title":"Thromb Haemost"},{"issue":"9836","key":"10.1016\/j.lanepe.2023.100784_bib236","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib237","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00392-015-0936-y","article-title":"Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial","volume":"105","author":"Proietti","year":"2016","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib238","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.115.018544","article-title":"Polypharmacy and the efficacy and safety of rivaroxaban versus warfarin in the prevention of stroke in patients with nonvalvular atrial fibrillation","volume":"133","author":"Piccini","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.lanepe.2023.100784_bib239","doi-asserted-by":"crossref","first-page":"i2868","DOI":"10.1136\/bmj.i2868","article-title":"Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial","volume":"353","author":"Jaspers Focks","year":"2016","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib240","first-page":"1099","article-title":"New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs","volume":"104","author":"Garcia","year":"2010","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.lanepe.2023.100784_bib241","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/ehjcvp\/pvaa117","article-title":"Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy","volume":"7","author":"Lip","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.lanepe.2023.100784_bib242","article-title":"The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","author":"Grymonprez","year":"2023","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib243","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/ehjcvp\/pvz061","article-title":"Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial","volume":"6","author":"Nicolau","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.lanepe.2023.100784_bib244","article-title":"Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis","author":"Zheng","year":"2023","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100784_bib245","article-title":"Effects of the atrial fibrillation better care pathway on outcomes among clinically complex Chinese patients with atrial fibrillation with multimorbidity and polypharmacy: a report from the ChiOTEAF registry","volume":"11","author":"Kotalczyk","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib246","article-title":"Comprehensive management with the ABC (atrial fibrillation better care) pathway in clinically complex patients with atrial fibrillation: a post hoc ancillary analysis from the AFFIRM trial","volume":"9","author":"Proietti","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib247","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.lanepe.2023.100784_bib248","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American heart association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100784_bib249","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/acem.12750","article-title":"There are sex differences in the demographics and risk profiles of emergency department (ED) patients with atrial fibrillation and flutter, but no apparent differences in ED management or outcomes","volume":"22","author":"Scheuermeyer","year":"2015","journal-title":"Acad Emerg Med"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib250","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.CIR.98.10.946","article-title":"Impact of atrial fibrillation on the risk of death: the Framingham Heart Study","volume":"98","author":"Benjamin","year":"1998","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib251","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.117.029081","article-title":"Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrillation: should we use a CHA(2)DS(2)-VA score rather than CHA(2)DS(2)-VASc?","volume":"137","author":"Nielsen","year":"2018","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.lanepe.2023.100784_bib252","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/ijcp.12625","article-title":"Gender differences in stroke prevention in atrial fibrillation in general practice: using the GRASP-AF audit tool","volume":"69","author":"Shantsila","year":"2015","journal-title":"Int J Clin Pract"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100784_bib253","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0002-9149(00)01077-8","article-title":"Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation","volume":"86","author":"Paquette","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lanepe.2023.100784_bib254","doi-asserted-by":"crossref","DOI":"10.1038\/srep42613","article-title":"Psychological stress and risk of incident atrial fibrillation in men and women with known atrial fibrillation genetic risk scores","volume":"7","author":"Svensson","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.lanepe.2023.100784_bib255","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.amjcard.2018.07.044","article-title":"Relationship between psychosocial stressors and atrial fibrillation in women >45 Years of age","volume":"122","author":"Westcott","year":"2018","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib256","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12872-019-1059-6","article-title":"Association of sex, age and education level with patient reported outcomes in atrial fibrillation","volume":"19","author":"Gleason","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib259","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281014","article-title":"Atrial fibrillation in UK South Asian hospitalized ischemic stroke patients: the BRAINS study","volume":"18","author":"Aurelius","year":"2023","journal-title":"PLoS One"},{"issue":"710","key":"10.1016\/j.lanepe.2023.100784_bib260","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.3399\/BJGP.2020.1021","article-title":"NHS Health Checks: an observational study of equity and outcomes 2009-2017","volume":"71","author":"Robson","year":"2021","journal-title":"Br J Gen Pract"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100784_bib261","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.006350","article-title":"Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (atherosclerosis risk in Communities)","volume":"11","author":"Mou","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"2","key":"10.1016\/j.lanepe.2023.100784_bib262","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.annepidem.2014.11.024","article-title":"Atrial fibrillation incidence and risk factors in relation to race-ethnicity and the population attributable fraction of atrial fibrillation risk factors: the Multi-Ethnic Study of Atherosclerosis","volume":"25","author":"Rodriguez","year":"2015","journal-title":"Ann Epidemiol"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib263","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1186\/s12889-022-14403-2","article-title":"Global, regional, and national burden of disease study of atrial fibrillation\/flutter, 1990-2019: results from a global burden of disease study, 2019","volume":"22","author":"Li","year":"2022","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.lanepe.2023.100784_bib264","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jamacardio.2016.1025","article-title":"Racial differences in atrial fibrillation-related cardiovascular disease and mortality: the atherosclerosis risk in Communities (ARIC) study","volume":"1","author":"Magnani","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccep.2020.10.010","article-title":"Epidemiology of atrial fibrillation: geographic\/ecological risk factors, age, sex, genetics","volume":"13","author":"Zhang","year":"2021","journal-title":"Card Electrophysiol Clin"},{"issue":"6","key":"10.1016\/j.lanepe.2023.100784_bib266","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ehjqcco\/qcaa061","article-title":"Global, regional, and national prevalence, incidence, mortality, and risk factors for atrial fibrillation, 1990-2017: results from the Global Burden of Disease Study 2017","volume":"7","author":"Dai","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"7","key":"10.1016\/j.lanepe.2023.100784_bib267","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/heartjnl-2020-317915","article-title":"Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China","volume":"107","author":"Du","year":"2021","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.lanepe.2023.100784_bib268","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/eurheartj\/ehp076","article-title":"Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men","volume":"30","author":"Rosengren","year":"2009","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.lanepe.2023.100784_bib269","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1080\/14779072.2018.1533118","article-title":"Associations between socioeconomic status, atrial fibrillation, and outcomes: a systematic review","volume":"16","author":"Lunde","year":"2018","journal-title":"Expet Rev Cardiovasc Ther"},{"key":"10.1016\/j.lanepe.2023.100784_bib270","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ijcard.2015.09.027","article-title":"Neighbourhood socio-economic status and all-cause mortality in adults with atrial fibrillation: a cohort study of patients treated in primary care in Sweden","volume":"202","author":"Wandell","year":"2016","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.lanepe.2023.100784_bib271","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ehjqcco\/qcz053","article-title":"Socioeconomic differences in outcomes after hospital admission for atrial fibrillation or flutter","volume":"7","author":"Hagengaard","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"1","key":"10.1016\/j.lanepe.2023.100784_bib272","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12889-022-12628-9","article-title":"Socioeconomic and geographic differences in ablation of atrial fibrillation in Norway - a national cohort study","volume":"22","author":"Olsen","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.lanepe.2023.100784_bib273","article-title":"Socioeconomic factors and bleeding events in patients with incident atrial fibrillation: a Finnish nationwide cohort study","volume":"43","author":"Teppo","year":"2022","journal-title":"Int J Cardiol Heart Vasc"},{"issue":"21","key":"10.1016\/j.lanepe.2023.100784_bib299","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622300203X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622300203X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:58:48Z","timestamp":1763009928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266677622300203X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":300,"alternative-id":["S266677622300203X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100784","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation: comorbidities, lifestyle, and patient factors","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100784","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100786","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100785","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100827","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100801","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2023.100797","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100784"}}